1227382-01-5 Usage
Description
tert-Butyl 2,6-diazaspiro[3.3]heptane-2-carboxylate oxalate is a complex organic compound that belongs to the category of synthetic chemicals. It is characterized by a cyclic diazaspiro[3.3]heptane core, a tert-butyl group, a carboxylate ester, and an oxalate group, which together suggest a wide range of potential reactivity and applications in advanced fields such as pharmaceuticals or materials science.
Uses
Used in Pharmaceutical Industry:
tert-Butyl 2,6-diazaspiro[3.3]heptane-2-carboxylate oxalate is used as a building block or intermediate in the synthesis of certain drugs or molecular compounds. Its unique structure and multiple functional groups allow for versatile reactivity, making it a valuable component in the development of new pharmaceuticals.
Used in Materials Science:
tert-Butyl 2,6-diazaspiro[3.3]heptane-2-carboxylate oxalate is used as a component in the creation of novel materials with specific properties. Its complex structure and functional groups can contribute to the development of advanced materials with applications in various industries, such as electronics, coatings, or adhesives.
As with any chemical substance, appropriate caution should be used when handling or using tert-Butyl 2,6-diazaspiro[3.3]heptane-2-carboxylate oxalate to ensure safety and effectiveness in its intended applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1227382-01-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,7,3,8 and 2 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1227382-01:
(9*1)+(8*2)+(7*2)+(6*7)+(5*3)+(4*8)+(3*2)+(2*0)+(1*1)=135
135 % 10 = 5
So 1227382-01-5 is a valid CAS Registry Number.
1227382-01-5Relevant articles and documents
HETEROCYCLIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE
-
Page/Page column 69, (2010/11/03)
Heterocyclic compounds of structural formula I are inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD). The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease; atherosclerosis; obesity; diabetes; neurological disease; Metabolic Syndrome; insulin resistance; cancer, liver steatosis; and non-alcoholic steatohepatitis.